chr20-59301498-AGAGACTGTGGCTGGCCCTGGCGAG-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 4P and 12B. PM2PM4BP6_Very_StrongBS1
The ENST00000337938.7(EDN3):βc.167_190delβ(p.Glu56_Glu63del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,613,646 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (β β ).
Frequency
Genomes: π 0.00072 ( 0 hom., cov: 32)
Exomes π: 0.00016 ( 0 hom. )
Consequence
EDN3
ENST00000337938.7 inframe_deletion
ENST00000337938.7 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0640
Genes affected
EDN3 (HGNC:3178): (endothelin 3) The protein encoded by this gene is a member of the endothelin family. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions. The active form of this protein is a 21 amino acid peptide processed from the precursor protein. The active peptide is a ligand for endothelin receptor type B (EDNRB). The interaction of this endothelin with EDNRB is essential for development of neural crest-derived cell lineages, such as melanocytes and enteric neurons. Mutations in this gene and EDNRB have been associated with Hirschsprung disease (HSCR) and Waardenburg syndrome (WS), which are congenital disorders involving neural crest-derived cells. Altered expression of this gene is implicated in tumorigenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in ENST00000337938.7.
BP6
Variant 20-59301498-AGAGACTGTGGCTGGCCCTGGCGAG-A is Benign according to our data. Variant chr20-59301498-AGAGACTGTGGCTGGCCCTGGCGAG-A is described in ClinVar as [Likely_benign]. Clinvar id is 504086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-59301498-AGAGACTGTGGCTGGCCCTGGCGAG-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000716 (109/152144) while in subpopulation AFR AF= 0.00214 (89/41502). AF 95% confidence interval is 0.00178. There are 0 homozygotes in gnomad4. There are 60 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDN3 | NM_207034.3 | c.167_190del | p.Glu56_Glu63del | inframe_deletion | 2/5 | ENST00000337938.7 | NP_996917.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDN3 | ENST00000337938.7 | c.167_190del | p.Glu56_Glu63del | inframe_deletion | 2/5 | 1 | NM_207034.3 | ENSP00000337128 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000717 AC: 109AN: 152028Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
109
AN:
152028
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000257 AC: 64AN: 249414Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135122
GnomAD3 exomes
AF:
AC:
64
AN:
249414
Hom.:
AF XY:
AC XY:
26
AN XY:
135122
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000160 AC: 234AN: 1461502Hom.: 0 AF XY: 0.000142 AC XY: 103AN XY: 727078
GnomAD4 exome
AF:
AC:
234
AN:
1461502
Hom.:
AF XY:
AC XY:
103
AN XY:
727078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000716 AC: 109AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000807 AC XY: 60AN XY: 74388
GnomAD4 genome
AF:
AC:
109
AN:
152144
Hom.:
Cov.:
32
AF XY:
AC XY:
60
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2021 | - - |
EDN3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 24, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at